Targeted delivery of human pro-apoptotic enzymes to tumor cells: In vitro studies describing a novel class of recombinant highly cytotoxic agents

Molecular Cancer Therapeutics

Volumn 2, Issue 12, 2003, Pages 1341-1350

  Liu, Yuying ^a   Cheung, Lawrence H ^a   Hittelman, Walter N ^a   Rosenblum, Michael G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GRANZYME; GZMB PROTEIN, HUMAN; HYBRID PROTEIN; PRIMER DNA; SERINE PROTEINASE;

APOPTOSIS; ARTICLE; CONFOCAL MICROSCOPY; DRUG EFFECT; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; IN VITRO STUDY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; CLONING, MOLECULAR; DNA PRIMERS; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRANZYMES; HUMANS; MICROSCOPY, CONFOCAL; RECOMBINANT FUSION PROTEINS; SERINE ENDOPEPTIDASES;

EID: 1642284083     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Lobe, C. G., Havele, C., and Bleackley, R. C. Cloning of two genes that are specifically expressed in activated cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA, 83: 1448-1454, 1986.
2. Trapani, J. A., Klein, J., White, P. C., and Dupont, B. Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes. Proc. Natl. Acad. Sci. USA, 85: 6924-6928, 1988.
3. Henkart, P. A. Mechanism of lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol., 3: 31-58, 1985.
4. Smyth, M. J. and Trapani, J. A. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol. Today, 16: 202-206, 1995.
5. Podack, E. R. Perforin: structure, function, and regulation. Curr. Top. Microbiol. Immunol., 178: 175-184, 1992.
6. Yagita, H., Nagata, M., Kawasaki, A., Shinkai, Y., and Okumura, K. Role of perforin in lymphocyte-mediated cytolysis. Adv. Immunol., 51: 215-242, 1992.
7. Froelich, C. J., Orth, K., Turbov, J., Seth, P., Gottleib, R., Babior, B., Shah, G. M., Bleackley, R. C., Dixit, V. M., and Hanna, W. New paradigm for lymphocyte granule-mediated cytotoxicity: target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. J. Biol. Chem., 271: 29073-29079, 1996. (Pubitemid 26382614)
8. Pinkoski, M. J., Hobman, M., Heibein, J. A., Tomaselli, K., Li, F., Seth, P., Froelich, C. J., and Bleackley, R. C. Entry and trafficking of granzyme B in target cells during granzyme B-perforin-mediated apoptosis. Blood, 92: 1044-1054, 1998. (Pubitemid 28355489)
9. Browne, K. A., Blink, E., Sutton, V. R., Froelich, C. J., Jans, D. A., and Trapani, J. A. Cytosolic delivery of granzyme B by bacterial toxins: evidence that endosomal disruption, in addition to transmembrane pore formation, is an important function of perforin. Mol. Cell. Biol., 19: 8604-8615, 1999. (Pubitemid 30414053)
10. Shi, L., Kraut, R. P., Aebersold, R., and Greenberg, A. H. A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J. Exp. Med., 175: 553-566, 1992.
11. Darmon, A. J., Nicholson, D. W., and Bleackley, R. C. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature, 377: 446-448, 1995.
12. Gu, Y., Sarnecki, C., Fleming, M. A., Lippke, J. A., Bleackley, R. C., and Su, M. S. S. Processing and activation of CMH-1 by granzyme B. J. Biol. Chem., 271: 10816-10820, 1996. (Pubitemid 26149901)
13. Orth, K., Chinnaiyan, A. M., Garg, M., Froelich, C. J., and Dixit, V. M. The CED-3/ICE-like proteaseMch2is activated during apoptosis and cleaves the death substrate lamin A. J. Biol. Chem., 271: 16443-16446, 1996. (Pubitemid 26238991)
14. Duan, H. J., Orth, K., Chinnaiyan, A. M., Poirier, G. G., Froelich, C. J., He, W. W., and Dixit, V. M. ICE-LAP6, a novel member of the ICE/ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J. Biol. Chem., 271: 16720-16724, 1996. (Pubitemid 26239035)
15. Fernandes-Alnemri, T., Armstrong, R. C., Krebs, J., Srinivasula, S. M., Wang, L., Bullrich, F., Fritz, L. C., Trapani, J. A., Tomaselli, K. J., Litwack, G., and Alnemri, E. S. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA, 93: 7464-7469, 1996. (Pubitemid 26277057)
16. Vincenz, C. and Dixit, V. M. Fas-associated death domain protein interleukin-1h-converting enzyme 2 (FLICE2), an ICE/ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling. J. Biol. Chem., 272: 6578-6583, 1997. (Pubitemid 27118141)
17. Yang, X., Stennicke, H. R., Wang, B., Green, D. R., Janicke, R. U., Srinivasan, A., Seth, P., Salvesen, G. S., and Froelich, C. J. Granzyme B mimics apical caspases. Description of a unified pathway for transactivation of executioner caspase-3 and -7. J. Biol. Chem., 273: 34278-34283, 1998. (Pubitemid 29008904)
18. Sutton, V. R., Davis, J. E., Cancilla, M., Johnstone, R. W., Ruefli, A. A., Sedelies, K., Browne, K. A., and Trapani, J. A. Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation. J. Exp. Med., 192: 1403-1414, 2000.
19. Barry, M. and Bleackley, C. Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol., 2: 401-409, 2002. (Pubitemid 37328747)
20. Jans, D. A., Jans, P., Briggs, L. J., Sutton, V., and Trapani, J. A. Nuclear transport of granzyme B (fragmentin-2). Dependence on perforin in vivo and cytosolic factors in vitro . J. Biol. Chem., 271: 30781-30789, 1996.
21. Trapani, J. A., Browne, K. A., Smyth, M. J., and Jans, D. A. Localization of granzyme B in the nucleus. J. Biol. Chem., 271: 4127-4133, 1996.
22. Trapani, J. A., Jans, D. A., Jans, P. J., Smyth, M. J., Browne, K. A., and Sutton, V. R. Efficient nuclear targeting of granzyme B and the nuclear consequences of apoptosis induced by granzyme B and perforin are caspase-dependent, but cell death is caspase-independent. J. Biol. Chem., 273: 27934-27938, 1998. (Pubitemid 28496083)
23. Heibein, J. A., Barry, M., Motyka, B., and Bleakley, R. C. Granzyme B-induced loss of mitochondrial inner membrane potential (Δψm) and cytochrome c release are caspase independent. J. Immunol., 163: 4683-4693, 1999. (Pubitemid 29501228)
24. Liu, Y., Cheung, L. H., and Rosenblum, M. G. Mechanistic studies of the cytotoxic action of the antimelanoma fusion toxin scFvMEL/TNF. Proc. Am. Assoc. Cancer Res., 43: 913 (Abstract # 4525), 2002.
25. Rosenblum, M. G., Cheung, L. H., Liu, Y., and Marks, J. W., 3rd. Design, expression, purification, and characterization, in vitro and in vivo, of an antimelanoma single chain Fv antibody fused to the toxin gelonin. Cancer Res., 63: 3995-4002, 2003. (Pubitemid 36917918)
26. Kantor, R. R., Ng, A. K., Giacomini, P., and Ferrone, S. Analysis of the NIH workshop monoclonal antibodies to human melanoma antigens. Hybridoma, 1: 473-482, 1982. (Pubitemid 13240596)
27. Macey, D. J., Denardo, S. J., Denardo, G. L., Goodnight, J. K., and Unger, M. W. Uptake of indium-111-labeled monoclonal antibody ZME-018 as a function of tumor size in a patient with melanoma. Am. J. Physiol. Imag., 3: 1-6, 1988.
28. Koizumi, M., Endo, K., Watanabe, Y., Saga, T., Sakahara, H., and Konishi, J. Immunoscintigraphy and pharmacokinetics of indium-111-labeled ZME-018 monoclonal antibody in patients with malignant melanoma. Jpn. J. Cancer Res., 79: 973-981, 1988.
29. Rosenblum, M. G., Murray, J. L., Cheung, L., Rifkin, R., Salmon, S., and Bartholomew, R. A. Specific and potent immunotoxin composed of antibody ZME-018 and the plant toxin gelonin. Mol. Biother., 3: 6-13, 1991.
30. Mujoo, K., Cheung, L., Murray, J. L., and Rosenblum, M. G. Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the anti-melanoma immunotoxin ZME-gelonin. Cancer Immunol. Immunother., 40: 339-345, 1995.
31. Rosenblum, M. G., Cheung, L., Mujoo, K., and Murray, J. L. An antimelanoma immunotoxin containing recombinant human tumor necrosis factor: tissue disposition, pharmacokinetics, and therapeutic studies in xenograft models. Cancer Immunol. Immunother., 40: 322-328, 1995.
32. Rosenblum, M. G., Horn, S. A., and Cheung, L. H. A novel recombinant fusion toxin targeting HER-2/neu-overexpressing cells and containing human tumor necrosis factor. Int. J. Cancer, 88: 267-273, 2000.
33. Poe, M., Blake, J. T., Boulton, D. A., Gammon, M., Sigal, N. H., Wu, J. K., and Zwerink, H. J. Human cytotoxic lymphocyte granzyme B. J. Biol. Chem., 266: 98-103, 1991.
34. Nishikawa, K., Rosenblum, M. G., Newman, R. A., Pandita, T., Hittelman, W. N., and Donato, N. J. Resistance of human cervical carcinoma cells to tumor necrosis factor correlated with their increased sensitivity to cisplatin: evidence of a role for epidermal growth factor receptor. Cancer Res., 52: 4758-4765, 1992.
35. Smyth, M. J., McGuire, M. J., and Thia, K. Y. Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I. J. Immunol., 154: 6299-6305, 1995.
36. Appelbaum, F. R. Antibody-targeted therapy for myeloid leukemia (review). Semin. Hematol., 36 (Suppl. 6): 2-8, 1999. (Pubitemid 29489654)
37. Dosio, F., Brusa, P., Delprino, L., Grosa, G., Ceruti, M., and Cattel, L. A new approach in the synthesis of immunotoxins: ribosome inactivating protein noncovalently bound to monoclonal antibody. J. Pharm. Sci., 83: 206-211, 1994. (Pubitemid 24224178)
38. Tallman, M. S. Monoclonal antibody therapies in leukemias. Semin. Hematol., 39 (Suppl. 3): 12-19, 2002. (Pubitemid 35417144)
39. Veenendaal, L. M., Jin, H., Ran, S., Cheung, L., Navone, N., Marks, J. W., Waltenberger, J., Thorpe, P., and Rosenblum, M. G. In vitro and in vivo studies of a VEGF121/rGel chimeric fusion toxin targeting the neovasculature of solid tumors. Proc. Natl. Acad. Sci. USA, 99: 7866-7871, 2002. (Pubitemid 34650971)
40. Scherf, U., Benhar, I., Webber, K. O., Pastan, I., and Brinkmann, U. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1 (Fv) fusion protein on Ley antigen-expression human cancer cells. Clin. Cancer Res., 2: 1523-1531, 1996. (Pubitemid 126447446)
41. Ferguson, M. J., Ahmed, F. Y., and Cassidy, J. The role of pro-drug therapy in the treatment of cancer. Drug Resist. Updat., 4: 225-232, 2001. (Pubitemid 34456376)
42. Newton, D. L., Hansen, H. J., Liu, H., Ruby, D., Iordanov, M. S., Magun, B. E., Goldenberg, D. M., and Rybak, S. M. Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents. Crit. Rev. Oncol./Hematol., 39: 79-86, 2001. (Pubitemid 32551990)
43. Motyka, B., Korbutt, G., Pinkoski, M. J., Heibein, J. A., Caputo, A., Hobman, M., Barry, M., Shostak, I., Sawchuk, T., Holmes, C. F., Gauldie, J., and Bleackley, R. C. Mannose-6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T-cell-induced apoptosis. Cell, 103: 491-500, 2000.
44. Johnson, H., Scorrano, L., Korsmeyer, S. J., and Ley, T. J. Cell death induced by Granzyme C. Blood, 101: 3093-3101, 2003. (Pubitemid 36858001)